New study reveals flaws in AI tools used for SARS-CoV-2 antibody discovery Post author: Post published:January 19, 2024 Post category:uncategorized A discovery program for SARS-CoV-2-nABs potentially targeting its resistant strains. You Might Also Like Frailty linked to diminished quality of life in cancer and transplant survivors October 2, 2024 Brain processes immediate goals faster than distant ones June 25, 2024 New molecular mechanisms linked to insulin resistance February 19, 2025